Revvity (0KHE) - Total Liabilities
Based on the latest financial reports, Revvity (0KHE) has total liabilities worth $4.92 Billion USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Revvity - Total Liabilities Trend (1985–2025)
This chart illustrates how Revvity's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Revvity Competitors by Total Liabilities
The table below lists competitors of Revvity ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Max Healthcare Institute Limited
NSE:MAXHEALTH
|
India | Rs62.29 Billion |
|
Danone PK
OTCQX:DANOY
|
USA | $27.84 Billion |
|
Guidewire Software Inc
NYSE:GWRE
|
USA | $1.18 Billion |
|
Aegon NV
AS:AGN
|
Netherlands | €301.25 Billion |
|
EastGroup Properties Inc
NYSE:EGP
|
USA | $1.94 Billion |
|
GEA GROUP
XETRA:G1A
|
Germany | €3.63 Billion |
|
Abivax SA American Depositary Shares
NASDAQ:ABVX
|
USA | $129.08 Million |
|
Universal Health Services Inc
NYSE:UHS
|
USA | $8.05 Billion |
Liability Composition Analysis (1985–2025)
This chart breaks down Revvity's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.68 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.68 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Revvity's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Revvity (1985–2025)
The table below shows the annual total liabilities of Revvity from 1985 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $4.92 Billion | +4.07% |
| 2024-12-31 | $4.73 Billion | 0.00% |
| 2024-12-29 | $4.73 Billion | -16.98% |
| 2023-12-31 | $5.69 Billion | -15.64% |
| 2023-01-01 | $6.75 Billion | +0.19% |
| 2022-12-31 | $6.73 Billion | -14.32% |
| 2022-01-02 | $7.86 Billion | -0.33% |
| 2021-12-31 | $7.89 Billion | +86.64% |
| 2021-01-03 | $4.22 Billion | -1.17% |
| 2020-12-31 | $4.27 Billion | +14.58% |
| 2019-12-31 | $3.73 Billion | +0.16% |
| 2019-12-29 | $3.72 Billion | +9.86% |
| 2018-12-31 | $3.39 Billion | 0.00% |
| 2018-12-30 | $3.39 Billion | -5.51% |
| 2017-12-31 | $3.59 Billion | +69.02% |
| 2017-01-01 | $2.12 Billion | 0.00% |
| 2016-12-31 | $2.12 Billion | +3.27% |
| 2016-01-03 | $2.06 Billion | +1.34% |
| 2015-12-31 | $2.03 Billion | -3.04% |
| 2014-12-31 | $2.09 Billion | +0.33% |
| 2014-12-28 | $2.09 Billion | +6.69% |
| 2013-12-31 | $1.95 Billion | +0.12% |
| 2013-12-29 | $1.95 Billion | -0.50% |
| 2012-12-31 | $1.96 Billion | 0.00% |
| 2012-12-30 | $1.96 Billion | -1.78% |
| 2011-12-31 | $2.00 Billion | +55.62% |
| 2010-12-31 | $1.28 Billion | -10.57% |
| 2009-12-31 | $1.44 Billion | +5.24% |
| 2008-12-31 | $1.36 Billion | -0.74% |
| 2007-12-31 | $1.37 Billion | +47.34% |
| 2006-12-31 | $932.59 Million | -10.58% |
| 2005-12-31 | $1.04 Billion | -6.50% |
| 2004-12-31 | $1.12 Billion | -11.38% |
| 2003-12-31 | $1.26 Billion | -20.53% |
| 2002-12-31 | $1.58 Billion | +1.82% |
| 2001-12-31 | $1.56 Billion | +1.55% |
| 2000-12-31 | $1.53 Billion | +31.62% |
| 1999-12-31 | $1.16 Billion | +48.22% |
| 1998-12-31 | $785.20 Million | +55.86% |
| 1997-12-31 | $503.80 Million | +10.05% |
| 1996-12-31 | $457.80 Million | +4.76% |
| 1995-12-31 | $437.00 Million | +25.68% |
| 1994-12-31 | $347.70 Million | +19.36% |
| 1993-12-31 | $291.30 Million | +5.51% |
| 1992-12-31 | $276.10 Million | -0.40% |
| 1991-12-31 | $277.20 Million | -9.29% |
| 1990-12-31 | $305.60 Million | +3.80% |
| 1989-12-31 | $294.40 Million | +42.22% |
| 1988-12-31 | $207.00 Million | -15.20% |
| 1987-12-31 | $244.10 Million | +16.85% |
| 1986-12-31 | $208.90 Million | -7.73% |
| 1985-12-31 | $226.40 Million | -- |
About Revvity
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectio… Read more